Drug Information and Monitoring System (DIMS), Trimbos Institute for Mental Health and Addiction, Utrecht, The Netherlands.
J Psychopharmacol. 2010 Sep;24(9):1395-401. doi: 10.1177/0269881109102541. Epub 2009 Mar 20.
A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.
一种新型迷幻药类似物质，间氯苯哌嗪（mCPP），已在荷兰街头毒品中被检测到。从理论上讲，mCPP 有可能成为一种非神经毒性替代品，用于取代亚甲二氧基甲基苯丙胺（MDMA），即摇头丸的常规精神活性物质。自从这种人工合成毒品在荷兰市场推出以来，含有 mCPP 的药片的比例一直在增加，包括仅含有 mCPP 的药片和含有 mCPP 和 MDMA 混合物的药片。这些药片有许多不同的颜色、形状和大小，还有各种标志，因此无法将含有 mCPP 的药片与常规的 MDMA 药片区分开来。此外，使用者对 mCPP 效果的报告主要是负面的。所有这些方面共同导致了这样的结论，即从使用者的角度来看，mCPP 是摇头丸市场中不受欢迎的添加物。
